The American Society of Hematology sent their
update today. You can read it by
clicking here.
In a novel break with their usual tradition, the
articles didn’t concentrate on money. There was loads of stuff in this instalment
including:
- Are CAR T-Cell Therapies Moving to Hodgkin Lymphoma?
- Beta-Thalassemia Gene Therapy Continues to Show Efficacy
- Adoptive “Non-Engineered” T-Cell Therapy Shows Preliminary Efficacy in Lymphomas
- Post-Transplant Ixazomib Maintenance Prolongs Survival in Newly Diagnosed Myeloma
No comments:
Post a Comment